BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34431262)

  • 1. Post COVID-19 Mucormycosis in the Second Wave-Realities, Uncertainties and Myths.
    Soman R; Sunavala A
    J Assoc Physicians India; 2021 Jul; 69(7):11-12. PubMed ID: 34431262
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19.
    Bonates P; João GAP; Cruz KS; Ferreira MS; Baía-da-Silva DC; Farias MEL; Brito-Sousa JD; Santana MF; Oliveira LA; Cortez ACA; Souza JVB; Lacerda MVG
    Rev Soc Bras Med Trop; 2021; 54():e03582021. PubMed ID: 34259759
    [No Abstract]   [Full Text] [Related]  

  • 3. Fulminant mucormycosis complicating coronavirus disease 2019 (COVID-19).
    Karimi-Galougahi M; Arastou S; Haseli S
    Int Forum Allergy Rhinol; 2021 Jun; 11(6):1029-1030. PubMed ID: 33713565
    [No Abstract]   [Full Text] [Related]  

  • 4. Mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum.
    Devnath P; Dhama K; Tareq AM; Emran TB
    Int J Surg; 2021 Aug; 92():106031. PubMed ID: 34311126
    [No Abstract]   [Full Text] [Related]  

  • 5. Rhino-orbital mucormycosis in a COVID-19 patient.
    Baskar HC; Chandran A; Reddy CS; Singh S
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34167998
    [No Abstract]   [Full Text] [Related]  

  • 6. Initial and ongoing challenges with COVID-19-associated mucormycosis.
    Sikka K; Goel G; Sharma N; Thakar A
    Indian J Ophthalmol; 2021 Dec; 69(12):3391-3393. PubMed ID: 34826965
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19-associated rhino-orbital mucormycosis: a single-centre experience of 10 cases.
    Arjun R; Felix V; Niyas VKM; Kumar MAS; Krishnan RB; Mohan V; Ansar A; Gautaam S; Lalitha S
    QJM; 2022 Jan; 114(11):831-834. PubMed ID: 34181023
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to: COVID-19-associated mucormycosis and evolving evidence.
    Sarda R; Swain S; Ray A; Wig N
    QJM; 2022 Jun; 115(6):422. PubMed ID: 34264346
    [No Abstract]   [Full Text] [Related]  

  • 9. Mucormycosis-Related Vision Loss in COVID-19.
    Dhoot SK
    Ophthalmic Surg Lasers Imaging Retina; 2022 Mar; 53(3):173-174. PubMed ID: 35272556
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.
    Rocha ICN; Hasan MM; Goyal S; Patel T; Jain S; Ghosh A; Cedeño TDD
    Trop Med Int Health; 2021 Sep; 26(9):1016-1018. PubMed ID: 34117677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post COVID-19 Mucormycosis - from the Frying Pan into the Fire.
    Soman R; Sunavala A
    J Assoc Physicians India; 2021 Jan; 69(1):13-14. PubMed ID: 34227768
    [No Abstract]   [Full Text] [Related]  

  • 12. Dental surveillance for Post-COVID mucormycosis.
    Balaji SM
    Indian J Dent Res; 2021; 32(1):2. PubMed ID: 34269227
    [No Abstract]   [Full Text] [Related]  

  • 13. The emergence of post-COVID-19 mucormycosis in India: Can we prevent it?
    Gupta A; Sharma A; Chakrabarti A
    Indian J Ophthalmol; 2021 Jul; 69(7):1645-1647. PubMed ID: 34146000
    [No Abstract]   [Full Text] [Related]  

  • 14. Dual hit - Magnetic resonance imaging in concomitant anterior and posterior ischemic optic neuropathy in a case of rhino-orbital mucormycosis and COVID-19.
    Kaushik KS; Acharya UV; Krupa L
    Indian J Ophthalmol; 2022 Jan; 70(1):300-301. PubMed ID: 34937262
    [No Abstract]   [Full Text] [Related]  

  • 15. Should statins be considered for the management of mucormycosis in COVID-19?
    Chatterjee S; Vardhan B; Singh DK; Maitra A; Ojha UK
    Diabetes Metab Syndr; 2021; 15(4):102162. PubMed ID: 34186353
    [No Abstract]   [Full Text] [Related]  

  • 16. Intestinal mucormycosis in a patient with COVID-19: A case report.
    Paliwal P; Rahar S; Sharma A; Gupta D; Ahuja A; Chauhan DS
    Indian J Pathol Microbiol; 2022; 65(2):475-477. PubMed ID: 35435400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palatal mucormycosis in a patient with SARS-CoV-2 infection.
    Venugopal A; Marya A
    CMAJ; 2021 Aug; 193(32):E1254. PubMed ID: 34400485
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 and Mucormycosis: Time we Answer Questions?
    Tandon A; Tandon S
    J Assoc Physicians India; 2021 Jul; 69(7):11-12. PubMed ID: 34431281
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 and orbital mucormycosis.
    Sarkar S; Gokhale T; Choudhury SS; Deb AK
    Indian J Ophthalmol; 2021 Apr; 69(4):1002-1004. PubMed ID: 33727483
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of mucormycosis in COVID-19 - the need of the hour.
    Ish P; Ish S
    Indian J Ophthalmol; 2021 Jul; 69(7):1969. PubMed ID: 34146076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.